ARCHIVES

NCI Director and Acting FDA Commissioner Andrew von Eschenbach Endorses Rep. E. Clay Shaw In Tour of Florida Congressman’s District. Von Eschenbach Praises Shaw’s “Leadership” In Seeking Funding For Research, Support of 2015 Goal.

This article is from The Cancer Letter archive.

Vol. 32 No. 04 | February 3, 2006

Download PDF Visit The Full Archive

Related Articles

Treatment Progress Increases Five Year Survival To 41%; Rates Compared For 10 Leading Cancers

April 25, 1980

Doxepin Rinse Reduces Pain In Radiation Therapy Patients

November 30, 2012

Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy

October 30, 1998

Activists To Seek $660 Million For Breast Cancer Research, Legislation To Declare An “Epidemic”

February 12, 1993

Drug Development Budget Cuts Force Early End To P388 Screening Contracts

January 9, 1987

NCI Lists ARRA Funding By Organ Site

September 18, 2009